Click here to sign up for the Nova Scotia Health Innovation Hub newsletter and never miss an update
News Article
Health Innovation Hub Milestones
June 15, 2023
3
Min Read
Using innovation and research to solve health challenges and transform care for Nova Scotians 2018 – Dr. Gail Tomblin Murphy, Vice President of Research, Innovation and Discovery and Chief Nursing Executive, launched the Research and Innovation portfolio with the vision...
page
Clinical Research Glossary
innovationhub.nshealth.ca/research-quality-and-education/clinical-research-glossary
Adverse Drug Reaction (ADR) In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established, all noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions. The phrase responses to...
News Article
Breathing a Little Easier: Nova Scotia Health Plays Important Role in Development of New Cystic Firbosis Drug
March 1, 2022
3
Min Read
From a very young age, those living with Cystic Fibrosis are aware that they have a life-threatening condition, and that their future might be uncertain. A new drug that has been referred to as the biggest innovation in cystic fibrosis...
page
Department of Health and Wellness' Priority Research Fund 2026
innovationhub.nshealth.ca/grants-and-funding-opportunities/department-health-and-wellness-priority-research-fund-2026
Anticipated Competition Timeline: Deadline Date Application Launch March 16, 2026 Full Application Deadline May 1, 2026 Dissemination of Competition Results Summer 2026 Program Overview The Department of Health and Wellness (DHW) 2026 Priority Fund will support targeted projects dedicated to work that align with the province’s health research priorities. This...
News Article
Nova Scotia Health launching mental health and addictions Text4Support research study
October 3, 2022
2
Min Read
Nova Scotia Health’s Mental Health and Addictions Program, in collaboration with Nova Scotia Health Innovation HUB and the QEII Foundation, have launched a research study on supportive text messages for mental health and addictions clients aged 18 and up accessing...
News Article
Pushing cancer care forward: a global first in clinic trials
April 9, 2024
2
Min Read
By: Kirsten Millar Our small East Coast province is putting itself on the map once again with a new, groundbreaking advance in cancer care. The QEII Health Sciences Centre in Halifax has become the first global site for a new...
page
Frequently Used and Approved RID Contract Templates
innovationhub.nshealth.ca/support-and-resources/contracts/frequently-used-and-approved-rid-contract-templates
Master Agreements To improve negotiation timelines and to ensure mutually agreeable terms and conditions between and amongst RID and external parties, master agreement templates are negotiated. These master agreements are in force for 2-3 years as negotiated. The parties to the agreement are the external third party and Nova Scotia...
News Article
The Nova Scotia Health Innovation Hub is proud to welcome four Dalhousie University Corporate Residency MBA Students to our team this semester. Learn more about Shawn Adderley, a former Zookeeper with a Masters of Science in Pharmacology.
April 22, 2022
5
Min Read
Tell us a little bit about yourself! My name is Shawn Adderley and I am from Dartmouth, NS. I defended my MSc in Pharmacology from Dalhousie University last summer and started the MBA program one week later. I previously worked...
News Article
Dr. Amanda Caissie named Nova Scotia Health Innovation Hub’s newest Innovator in Residence
May 16, 2023
2
Min Read
By Laura Todesco The Nova Scotia Health Innovation Hub has named Dr. Amanda Caissie as an Innovator in Residence. Dr. Caissie is a global leader in digital oncology focused on patient impact that is driving change for Nova Scotians. “We...
News Article
Can we do better? Two international clinical trials in Nova Scotia investigate new cancer treatments
April 21, 2026
3
Min Read
When cancer is rare, aggressive, and difficult to treat, standard therapies can be limited. Patients and clinicians grappling with this reality are left asking: what else might help? Two new clinical trials now open in Nova Scotia are trying to...
